Abstracts

Citation

Edward P. Acosta, Pharm.D., Andrew A. Wiznia, M.D., Sharon Appelbaum Nachman, M.D., Hedy Teppler, M.D., Mary C. Long, Ph.D., B. Homony, Edward Handelsman, M.D., Carol J. Worrell, M.D., Terence Fenton, Ed.D. Raltegravir pharmacokinetics in adolescents: preliminary results from IMPAACT protocol 1066. Presented at: 9th Int'l Workshop on Clinical Pharmacology of HIV Therapy.

Citation

Miriam Chernoff, Ph.D., Kenneth D. Gadow, Ph.D. Challenges for treating psychiatric disorders in pediatric HIV-infection. Presented at: 68th Annual Meeting of the Society for Applied Anthropology.

Citation

Edmund Capparelli, Pharm.D., Jorge Pinto, M.D., D.Sc., Brian Robbins, Ph.D., Carmelita Alvero, Ram Yogev, M.D., Paul Palumbo, M.D., John H. Rodman, Pharm.D., Barbara E. Heckman, B.S., Ellen Gould Chadwick, M.D. Lopinavir pharmacokinetic (PK) maturational changes and variability in HIV-infected infants beginning Kaletra (LPV/r) therapy at < 6 weeks (WK) of age. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Mark Mirochnick, M.D., Karin Alvarenga-Hyldgaard Nielsen, M.D., M.P.H., Jose Henrique Pilotto, M.D., Jorge Pinto, M.D., D.Sc., Valdilea V. Santos, M.D., Ph.D., Diane Holland, M.Phil., Heather D. Watts, M.D., John ( Jack ) Moye, Jr., M.D., Lynne M. Mofenson, M.D., F.A.A.P., Yvonne J. Bryson, M.D. Nelfinavir pharmacokinetics with an increased dose during the first two weeks of life. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Thomas C. Greenough, M.D., Coleen K. Cunningham, M.D., Margaret McManus, B.S., Lawrence Fox, M.D., Ph.D., Petronella Muresan, M.S., Deborah Persaud, M.D., Dennis Panicali, Ph.D., John L. Sullivan, M.D., Katherine Luzuriaga, M.D. Augmentation of HIV-1 specific cell-mediated immune responses following vaccination with recombinant modified vaccinia ankara (MVA)-fowlpox (FP) vaccines in HIV-1-infected young adults on suppressive antiretroviral (ARV) therapy. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Tammy Meyers, M.D., Richard M. Rutstein, M.D., Pearl Samson, M.S., Avy Violari, M.D., Jennifer J. Kiser, Pharm.D., Courtney V. Fletcher, Pharm.D., Terence Fenton, Ed.D., Lynne M. Mofenson, M.D., F.A.A.P., Bobbie L. Graham, B.S., Steven M. Schnittman, M.D., Maria-Arantxa Horga, M.D., Grace M. Aldrovandi, MD. Treatment responses to atazanavir-containing HAART in a drug-naive paediatric population in South Africa. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Kumud K. Singh, Ping Ruan, Ph.D., Terence Fenton, Ed.D., Stephen A. Spector, M.D. Genetic variants of toll-like receptors-2, -4, and -9 are not associated with HIV-1 disease in children. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Ada Cachafeiro, Glenn Sherman, Ph.D., A. Sohn, C. Beck-Sague, Susan A. Fiscus, Ph.D. Dried blood spots and the ultra-sensitive p24 antigen assay for the diagnosis of perinatal HIV infection. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Jessica D. Church, S. Omer, Laura A. Guay, M.D., Wei Huang, Philippa Musoke, MB ChB, Francis Mmiro, Brooks Jackson, M.D., M.B.A., Susan H. Eshleman, M.D., PH.D. Analysis of NVP resistance in Ugandan infants who were HIV-infected despite receiving single-dose nevirapine vs. single-dose NVP plus up to 6 weeks of daily NVP to prevent HIV vertical transmission. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

S. Trzmielina, Nishaki Mehta, M. Eliot, Aletta B. Nonyane, Andrea S. Foulkes, John L. Sullivan, M.D., Katherine Luzuriaga, M.D., Mohan Somasundaran. A low-cost real-time PCR assay for HIV-1 diagnosis and quantification using dried blood spots. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.